Literature DB >> 19136933

Increased TRPC3 expression in vascular endothelium of patients with malignant hypertension.

Florian Thilo1, Christoph Loddenkemper, Erika Berg, Walter Zidek, Martin Tepel.   

Abstract

An increased expression of transient receptor potential canonical type 3 (TRPC3) cation channels has been proposed as one of the factors contributing to the pathogenesis of hypertension. To test that hypothesis we compared the expression of TRPC3 and TRPC6 as an endogenous control in human vascular endothelium of preglomerular arterioles in kidney biopsies from six patients with malignant hypertension and from four patients with diarrhea-associated hemolytic-uremic syndrome. Patients with malignant hypertension showed significantly higher systolic blood pressure and more prominent expression of TRPC3 in vascular endothelium of preglomerular arterioles compared to patients with hemolytic-uremic syndrome. The expression of TRPC6 was not different between the two groups. The study supports the hypothesis that the increased expression of TRPC3 is associated with malignant hypertension in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19136933     DOI: 10.1038/modpathol.2008.200

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  15 in total

Review 1.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 2.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

3.  Serine-threonine kinase with-no-lysine 4 (WNK4) controls blood pressure via transient receptor potential canonical 3 (TRPC3) in the vasculature.

Authors:  Hyun Woo Park; Joo Young Kim; Soo-Kyoung Choi; Young-Ho Lee; Weizhong Zeng; Kyung Hwan Kim; Shmuel Muallem; Min Goo Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

Review 4.  On the role of endothelial TRPC3 channels in endothelial dysfunction and cardiovascular disease.

Authors:  K Smedlund; M Bah; G Vazquez
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2012-09

Review 5.  TRP-ing up heart and vessels: canonical transient receptor potential channels and cardiovascular disease.

Authors:  Janelle Rowell; Norimichi Koitabashi; David A Kass
Journal:  J Cardiovasc Transl Res       Date:  2010-07-22       Impact factor: 4.132

6.  Novel drugs targeting hypertension revisited.

Authors:  George W Booz
Journal:  J Cardiovasc Pharmacol       Date:  2010-09       Impact factor: 3.105

7.  Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.

Authors:  Jung Woo Han; Young Ho Lee; Su-In Yoen; Joel Abramowitz; Lutz Birnbaumer; Min Goo Lee; Joo Young Kim
Journal:  Mol Cell Biochem       Date:  2016-08-13       Impact factor: 3.396

8.  Update on vascular endothelial Ca(2+) signalling: A tale of ion channels, pumps and transporters.

Authors:  Francesco Moccia; Roberto Berra-Romani; Franco Tanzi
Journal:  World J Biol Chem       Date:  2012-07-26

9.  An elevation in physical coupling of type 1 inositol 1,4,5-trisphosphate (IP3) receptors to transient receptor potential 3 (TRPC3) channels constricts mesenteric arteries in genetic hypertension.

Authors:  Adebowale Adebiyi; Candice M Thomas-Gatewood; M Dennis Leo; Michael W Kidd; Zachary P Neeb; Jonathan H Jaggar
Journal:  Hypertension       Date:  2012-10-08       Impact factor: 10.190

10.  Inhibition of TRPC1/TRPC3 by PKG contributes to NO-mediated vasorelaxation.

Authors:  Jie Chen; Randy F Crossland; Muzamil M Z Noorani; Sean P Marrelli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.